2012 conventions 2012 election 2013 session arts arts and culture author ballot measures basketball bomb books boy scouts budget bullying business charlie hales children clackamas climate change coal college courts crime culture culture club democrats drugs economy education environment family film fluoride food gay rights guns handguns health health care health insurance high school history housing immigration internet kitzhaber language law legislature lgbt literary arts living marijuana marriage media medicine mental health military minor parties mohamed mohamud movies music native americans news newspaper obama olympics oregon our town parenting pers photography police politcs politics port portland portland business journal president prevention public safety religion republicans rnc romney rural salem sam adams sandy hook schools science shooting sports suicide supreme court taxes technology television terrorism theater third parties transportation union university of oregon washington wildfire women

The idea that drug and device development companies are 'greedy' and that's why they need to make a profit is just rediculous.

It cost > $100millions on average to develop a new drug. A device, comping from university research to the bedside can cost up to $100million. That money comes from somewhere...think about it. It comes from investors that make these VERY RISKY investments with the idea that one out of 10 will be profitable.

Without profitability on 1/10 new drug/devices, these investors CANT INVEST, and the drug/devices will not be available.

Don't complain about greed, that frankly naive and childish.

posted 3 years, 1 month ago
view in context